RESUMO
Background: In the manufacturing industry, work-related musculoskeletal disorders (MSD) result in sick days and have substantial economic consequences for the enterprise and the national economy. Exoskeletons can support the body when handling heavy loads and enduring enforced postures. Exoskeletons are being piloted particularly in large companies in the automotive industry; however, exoskeletons have so far attracted little interest in small and medium-sized enterprises (SME) and their use has so far barely been scientifically examined. The aim of this work was to determine barriers to exoskeleton implementation and expectations for their use in the manufacturing sector. Method: Semi-structured guided interviews in six manufacturing companies were carried out and analyzed. Results: In the enterprises a variety of activities up to the loading limits are carried out. Exoskeletons are generally expected to facilitate work and provide economic advantages. There are concerns with respect to their use due to cost factors, uncertain benefits and wearing discomfort. Particularly uncertainties about the effects of exoskeletons become evident. Conclusion: The presented interview results are one step in an interdisciplinary process of further developing and implementing exoskeletons in the manufacturing industry. Concerns and unawareness of potential enterprises and users must be addressed, also to achieve a high user acceptance. Further studies that survey the identification of needs with better discriminatory power could provide additional insights.
RESUMO
The aims were to examine the feasibility of and adaptations to endurance training in persons diagnosed with schizophrenia and to address the question whether the principles and beneficial effects of endurance training established in the healthy population apply also to patients with schizophrenia. In this controlled interventional study, 22 patients with schizophrenia and 22 healthy controls performed a standardized aerobic endurance training on bicycle ergometers over 12 weeks. Another group of 21 patients with schizophrenia played table soccer. Endurance capacity was measured with incremental cycle ergometry before and after the intervention and 3 months later. A specific set of outcome parameters was defined. The training stimuli can be assumed to be similar in both endurance groups. Endurance capacity improved significantly in the endurance groups, but not in the table soccer group. Patients and healthy controls showed comparable adaptations to endurance training, as assessed by physical working capacity and maximal achieved power. Differences were found in changes of performance at a lactate concentration of 3 mmol/l. Endurance training was feasible and effective in both groups. The principles and types of training that are usually applied to healthy controls need to be verified in patients with schizophrenia. Nevertheless, patients benefited from endurance training in terms of improvement of endurance capacity and reduction in the baseline deficit in comparison with healthy controls. Therefore, endurance training should be implemented in future therapy programs. These programs need to pay special attention to the differences between patients with schizophrenia and healthy controls.